Presented by Jim Thomas at the MEASURE Evaluation End-of-Phase-III Evant.

1. Global Health M&E: What’s Next?

2. The Distance We’ve Travelled

3. Bending the Curve
PEPFAR I
Phase II Phase III
2000 2005
2010 2014
UNAIDS Global Report, 2012
PEPFAR II

4. HIV incidence changes, 2001-2011
Adults 15-49 years old
UNAIDS Global Report, 2012

5. Bending the Curve
PEPFAR I PMI
PEPFAR II
Phase II Phase III
2000 2005 2010 2014
Murray, et al.
Lancet 2012;
379:413-31

6. Bending the Curve
Tuberculosis
WHO, Global TB Report, 2013

7. MEASURE Evaluation’s Contribution
Measuring change

8. MEASURE Evaluation’s Role
Building a workforce

9. MEASURE Evaluation’s Contribution
Strengthening systems

10. MEASURE Evaluation’s Contribution
Guiding the allocation of resources

11. MEASURE Evaluation’s Contribution
Creating tools and methods

12. MEASURE Evaluation’s Contribution
Global leadership

13. What’s
Next?

14. What’s Next?
Foundations Capacity Sustainability
Phase II Phase III Phase IV

15. What’s Next?
• Scale-up
 Systems
 Approaches
 Tools

16. What’s Next?
• Scale-up
• Fill gaps
 Interoperability of
data systems
 Evaluating structural
interventions
Photo: Landesa/Deborah Espinosa

17. What’s Next?
• Scale-up
• Fill gaps
• Systems thinking
 Public health decision-making
 Antretroviral therapy (ART) delivery

18. What’s Next?
• Scale-up
• Fill gaps
• Systems thinking
• Workforce
 Managing systems
 Conducting evaluations
 Training for sustainability

19. M&E as Public Health Infrastructure

20. Other Public Health Challenges

21. M&E as Public Health Infrastructure

22. We Thank:
 The American people
 USAID and PEPFAR
 Country collaborators
 Implementing partners
 You

23. Global Health M&E: What’s Next?
www.measureevaluation.org/eop